Baixar PDF

Outros usuários também visualizaram estes artigos

Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis Jaime Pinho, Miguel Carvalho, Mariana Paiva, Nuno Teixeira-Tavares, Cristina Costa-Santos, Carla Sousa
10.1016/j.repc.2022.10.016
Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking echocardiography Mehmet Şahinbaş, İdris Buğra Çerik, Duygu Yalınbaş Yeter
10.1016/j.repc.2024.07.006